EndoChoice updates earning guidance

EndoChoice has a consensus revenue estimate of $74.51 million for fiscal year 2015, according to an InterCooler report.

Last week, the company updated its revenue guidance to $72 million to $74 million for FY 2015.

EndoChoice stock has a 52-week high of $19.69 and a 52-week low of $7.37, according to the report.

More articles on gastroenterology:
Exact Sciences to open biotech campus & more – 3 GI company key notes
CMS cuts to colonoscopy reimbursement finalized: 3 things to know
6 recent must-reads on CRC screening & treatments

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months